Report of two cases of children with Budd-Chiari syndrome successfully treated with streptokinase.
Two children with Budd-Chiari syndrome were successfully submitted to thrombolytic therapy. This study suggests that streptokinase is safe and effective in the treatment of this syndrome and should be considered as primary treatment in case of early diagnosed acute disease in view of the poor prognosis and the aggressiveness of surgical treatment currently available.
Sawamura
R
R
Department of Pediatrics, Faculty of Medicine of RibeirãoPreto, University of São Paulo, Brazil.
Fernandes
M I
MI
Galvão
L C
LC
Goldani
H A
HA
D006502:Budd-Chiari Syndrome / Q000188:drug therapy*; D002648:Child; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D013300:Streptokinase / Q000627:therapeutic use*; D015912:Thrombolytic Therapy
D005343:Fibrinolytic Agents; D013300:Streptokinase